Международный опыт применения абатацепта для лечения рефрактерного увеита у пациентов с ювенильным идиопатическим артритом
Аннотация
Ключевые слова: дети, ювенильный идиопатический артрит, увеит, лечение, абатацепт, блокатор костимуляции лимфоцитов, биологический агент.
Об авторах
Р.В. ДенисоваЕ.И. Алексеева
Список литературы
1. Saurenmann R.K., Levin A.V., Feldman B.M. et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long term follow up study. Arthritis. Rheum. 2007; 56: 647–657.
2. Heiligenhaus A., Mingels A., Heinz C., Ganser G. Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti–inflammatory medication. Eur. J. Ophthalmol. 2007; 17: 743–748.
3. Tappeiner C., Roesel M., Heinz C. et al. Limited value of cyclosporine for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye. 2009; 23: 1192–1198.
4. Doycheva D., Deuter C., Stuebiger N. et al. Mycophenolate mofetil in the treatment of uveitis in children. Br. J. Ophthalmol. 2007; 91: 180–184.
5. Sharma S.M., Ramanan A.V., Riley P., Dick A.D. Use of infliximab in juvenile onset rheumatological disease associated refractory uveitis: efficacy in joint and ocular disease [letter]. Ann. Rheum. Dis. 2007; 66: 840–841.
6. Biester S., Deuter C., Michels H. et al. Adalimumab in the therapy of uveitis in childhood. Br. J. Ophthalmol. 2007; 91: 319–324.
7. Pettit A.R., Thomas R. Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis. Immunol. Cell. Biol. 1999; 7: 420–427.
8. Bretscher P.A. A two step, two signal model for the primary activation of precursor helper T– cells. Proc. Natl. Acad. Sci. USA. 1999; 96: 85–90.
9. Choy E.H., Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. New Engl. J. Med. 2001; 344: 907–916.
10. Yamada A., Salama A.D., Sayegh M.H. The role of novel T cell costimulatory pathways in autoimmunity and transplantation. J. Am. Soc. Nephrol. 2002; 13: 559–575.
11. Chambers C.A., Allison J.P. CTLA–4 — the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition. Cold. Spring. Harb. Symp. Quant. Biol. 1999; 64: 303–312.
12. Davies P., Zhou L., Abraham R. Abatacept binds to the Fc receptor CD64 but does not mediate complement dependent сytotoxicity or antibody dependent cellular cytotoxicity. J. Rheumatol. 2007; 34: 280–289.
13. Linsley P.S., Brady W., Urnes M. et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 1991; 174 (3): 561–569.
14. Ruperto N., Lovell D.J., Quartier P. et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo controlled withdrawal trial. Lancet. 2008; 372 (9636): 383–391.
15. Алексеева Е.И., Денисова Р.В., Валиева С.И. Абатацепт — новые возможности терапии ювенильного идиопатического артрита. Вопросы современной педиатрии. 2009; 8 (4): 84–89.
16. Angeles-Han S., Flynn T., Lehman T. Abatacept for refractory juvenile idiopathic arthritis-associated uveitis — a case report. J. Rheumatol. 2008; 35 (9): 1897–1898.
17. Zulian F., Balzarin M., Falcini F. Abatacept for Severe anti-tumor necrosis factor α refractory juvenile idiopathic arthritis — related uveitis. Arthritis. Care. Research. 2010; 62 (6): 821–825.
18. Kenawy N., Cleary G., Mewar D. Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis associated uveitis. Graefes. Arch. Clin. Exp. Ophthalmol. 2011; 249 (2): 297–300.
19. Elhai M., Deslandre C.J., Kahan A. Abatacept for refractory juvenile idiopathic arthritis-associated uveitis: two new cases.Arthritis. Care. Res. (Hoboken). 2011; 63 (2): 307–308.
20. Silver P.B., Hathcock K.S., Chan C.C. et al. Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long term tolerance. J. Immunol. 2000; 165: 5041–5047.
21. Shao H., Woon M.D., Nakamura S. et al. Requirement of B7–mediated costimulation in the induction of experimental autoimmune anterior uveitis. Invest. Ophthalmol. Vis. Sci. 2001; 42: 2016–2021.
22. Deschenes J., Char D.H., Kaleta S. Activated T lymphocytes in uveitis. Br. J. Ophthalmol. 1988; 72: 83–87.
23. Wang X.C., Norose K., Yano A. et al. Two color flow cytometric analysis of activated T lymphocytes in aqueous humor of patients with endogenous vs. exogenous uveitis. Curr. Eye. Res. 1995; 14: 425–433.
Рецензия
Для цитирования:
Денисова Р., Алексеева Е. Международный опыт применения абатацепта для лечения рефрактерного увеита у пациентов с ювенильным идиопатическим артритом. Вопросы современной педиатрии. 2011;10(5):39-44.
For citation:
Denisova R., Alexeeva E. INTERNATIONAL PRACTICE OF ABATACEPT USE IN TREATMENT OF REFRACTORY UVEITIS IN PATIENTS WITH IDIOPATHIC JUVENILE ARTHRITIS. Current Pediatrics. 2011;10(5):39-44.
Послать статью по эл. почте 
